PCGC Centers are recruiting individuals of all ages with congenital heart disease to obtain DNA as well as detailed phenotypic and clinical data, and will follow them over time to collect outcomes data. The PCGC will use state-of-the-art genetic techniques to interrogate the genome for single nucleotide polymorphisms and structural variations and to conduct high-throughput, large-scale sequencing. The biological samples, which will remain linked to detailed clinical data, will continue to serve as a resource for long-term investigations into the genetic basis of pediatric cardiovascular disorders. The PCGC will significantly increase understanding of the causes and modifiers of pediatric cardiovascular pathology, and over time will enhance early detection, treatment and prevention of congenital heart disease in newborns, children, and adults.

Authorized access to PCGC phenotype, sequence, and genotype data can be requested through dbGaP. Local IRB approval is required.

Learn more about PCGC Centers

CHD GENES Newsletter, February 2015

CHD GENES Newsletter, July 2013

Cohort Demographics

CHD Genes Enrollment

Subjects Enrolled: 11,007

Relatives Enrolled: 14,977

as of 6/30/2017